This brand name is authorized in Brazil
The drug ADDERA D3 contains one active pharmaceutical ingredient (API):
1
Vitamin D3
UNII 1C6V77QF41 - CHOLECALCIFEROL
|
In its biologically active form vitamin D3 stimulates intestinal calcium absorption, incorporation of calcium into the osteoid, and release of calcium from bone tissue. In the small intestine it promotes rapid and delayed calcium uptake. The passive and active transport of phosphate is also stimulated. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
A11CC05 | Colecalciferol | A Alimentary tract and metabolism → A11 Vitamins → A11C Vitamin A and D, incl. combinations of the two → A11CC Vitamin D and analogues |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 540914010012808, 540914010012908, 540914010013008, 540915040014703, 540915040014803, 540915040014903, 540916070019903, 540916090022903, 540917070032503, 540917070032603, 540917070032703, 540917070032803, 540917070032903, 540917080033003, 540917080033103, 540917080033203, 540917080033303, 540917080033403, 540919060038903, 540919060039003, 540919060039103, 540919060039803, 540919060039903, 540919060040003, 540919060040103, 540919120039707, 540919120039807, 540919120039907, 540921020044803, 540921020044903, 540921020045003, 540921020045103, 540921020045203, 540921020045303, 540921020045403 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.